Our group recently reported that TOR signaling pathway regulator like (TIPRL) protein is overexpressed in HCC and contributes to TRAIL resistance by forming the mitogen-activated protein kinase kinase 7 (MKK7)-protein phosphatase type 2A (PP2Ac)-TIPRL complex. The gene discussed is MAP2K7; the disease is hepatocellular carcinoma.